scPharmaceuticals Inc.
US ˙ NasdaqGS ˙ US8106481059
TEN SYMBOL NIE JEST JUŻ AKTYWNY

SecuritySCPH / scPharmaceuticals Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership67,137 shares
Latest Disclosed Value $ 255,791
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in SCPH / scPharmaceuticals Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 67,137 shares of scPharmaceuticals Inc. (US:SCPH) valued at $255,792 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 67,137 shares of scPharmaceuticals Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $380,667 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP scPharmaceuticals EC US8106481059 67,137 0 0.00 256 44.89 0.0057
2025-05-28 2025-03-31 NP scPharmaceuticals EC US8106481059 67,137 20,621 44.33 177 7.32 0.0042
2025-02-25 2024-12-31 NP scPharmaceuticals EC US8106481059 46,516 -13,346 -22.29 165 -39.71 0.0036
2024-11-26 2024-09-30 NP scPharmaceuticals EC US8106481059 59,862 0 0.00 273 4.62 0.0052
2024-08-26 2024-06-30 NP scPharmaceuticals EC US8106481059 59,862 10,384 20.99 260 4.84 0.0053
2024-05-28 2024-03-31 NP scPharmaceuticals EC US8106481059 49,478 0 0.00 248 -20.00 0.0052
2024-02-26 2023-12-31 NP scPharmaceuticals EC US8106481059 49,478 0 0.00 310 -11.93 0.0066
2023-11-28 2023-09-30 NP scPharmaceuticals EC US8106481059 49,478 0 0.00 352 -30.16 0.0092
2023-08-25 2023-06-30 NP scPharmaceuticals EC US8106481059 49,478 40,402 445.15 504 740.00 0.0120
2021-05-27 2021-03-31 NP scPharmaceuticals EC US8106481059 9,076 0 0.00 60 25.00 0.0014
2021-02-25 2020-12-31 NP scPharmaceuticals EC US8106481059 9,076 0 0.00 48 -28.36 0.0012
2020-11-25 2020-09-30 NP scPharmaceuticals EC US8106481059 9,076 0 0.00 68 1.52 0.0022
2020-08-27 2020-06-30 NP scPharmaceuticals EC US8106481059 9,076 9,076 67 0.0022
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.